We utilized the Amicon micropartitionsystem (MPS-1) to prepare ultrafiltratesof serum for evaluating non-proteinbound copper (NPBCu). The method is rapid (a usual turnaroundtime <2 h), practical(only1 mL of serum is required), and reproducible(average CV = 5.7% within assay and 9.3% between assays). Usingthis technique, we determined that (a) NPBCu in serum appeared to be fairly stable, showinglittlevariationamong subjects in differentphysiological conditions(normalfemale, pregnancy,or fetal samples); and (b) of all copperfractionsstudied,onlyNPBCu appeared to correlatebetween maternalconcentrationsand cordcounterpartsat delivery.Thus the NPBCu fractionmay be appreciablyInvolved in the overallmechanismof coppernutritional supplyfrom motherto fetus.
larly to the total copper concentration [total copper concentrations in serum during pregnancy being reportedly about twice those of nonpregnant females (6)1? (b) Does the concentration of NPBCu exhibit a pattern similar to the documented significant gradient that exists between maternal and fetal blood [maternal total copper in serum is about fivefold that of the fetus (7, 8) ]?
Materials and Methods
All chemicals used in the following investigations were of AnalaR grade and were obtained from BDH Chemicals Ltd., Poole, U.K.
Analyses
Ceruloplasmin and albumin were assayed by the Arraytm Protein System (Beckman Instruments Inc., Diagnostic
System Group, Brea, CA 92621) according to the manufacturer's recommended procedure, reagents, and quality controls.
To obtain the NPBCu fraction from serum, we used the micropartition system (Amicon MPS-1 Starter Kit; Ami- Effects of EDTA. To study the effect of adding EDTA, a copper-chelating agent, to serum on the concentration of NPBCu, we added various volumes of di-sodium EDTA solution (68 mmol/L) to 1-mL aliquots of pooled serum; the final volume was adjusted to 1.5 mL with de-ionized water. These samples (three replicates for each EDTA concentration) were incubated at 4#{176}C for 48 h; then the NPBCu, obtained after ultrafiltration, was quantified. This experiment was designed to show the ability of EDTA to chelate the loosely protein-boundcopper;accordingly,the maximal increase in NPBCu concentration should reflect the magnitude of the former fraction.
Clinical Samples
Total copper, NPBCu, and ceruloplasmin at second, and 51 at third trimester; all pregnancies were singleton and apparently proceeding normally, and intrauterine growth was within normal reference values for gestation, according to regular ultrasound examinations); 37 samples of cord-vein blood obtained immediately after vaginal delivery of normal, healthy, appropriate-for-date babies selected without consciousbias; and 18 paired specimens for maternal and cord blood obtained immediately after vaginal delivery of singleton uneventful pregnancies. Informed consent was procured in all cases.
Blood samples were drawn into plain red-top Vacutainer
Tubes (Becton Dickinson & Co., Rutherford, NJ 07070) and kept anaerobic by leaving the tubes stoppered during clotting and centrifugation at 6#{176}C. Afterward, the stoppers were removed and the serum was promptly transferred into screw-cap plastic tubes that were stored at -50 #{176}C until assayed for each analyte in as few batches as possible.
Statistical Analysis
Statistical analysesof data from this investigation were performed with the Statistical Package for Social Science (SPSS Inc., Chicago, IL 60611) on a computer. Techniques involved Pearson's correlation coefficient (r) to show the degree of linear associations among the variables studied and analysis of variance to test for differences between means whenever the case is a comparison of three or more groups. A two-tailed probability (P) of <0.05 was considered significant. Tables 4 and 5 . Cord blood samples showed no association between ceruloplasmin and total copper, whereas the relationship between total copper and NPBCu concentrations was significant (r = 0.345, NPBCu = 0.13 + 0.02 total copper). In contrast, separate data from the normal controls and the pregnant subjects indicate significant correlations between concentrations of total copper and ceruloplasmin but not with those of NPBCu (Table 4 ).
In paired specimens of cord and maternal blood, total copper concentration was higher in maternal blood, and the overall mean ratio of maternal to cord blood concentrations was -4.8. However, the linear correlation between total copper in maternal and cord blood was not statistically significant (r = -0.34, n = 18, P >0.05), nor was the relationship between maternal NPBCu and cord serum total copper significant (r = 0.048, P >0.05).
A more interesting finding was the highly significant and positive correlation between NPBCu concentrations in cord and maternal samples (r = 0.67, n = 18, P <0.01; cord NPBCu = 0.06 + 0.66 maternal NPBCu).
Discussion
Scientists have long speculated about aspects of copper metabolism in blood: the exact physiological role of ceruloplasmin, a nonexchangeable carrier of the majority of copper found in plasma; the extent, distribution, and significance of the loosely protein-bound copper, and the importance of the minute copper fraction that is not bound to proteins. Only a few published studies have been related to the behavior and distribution of the loosely protein-bound and non-proteinbound copper fractions in physiological and pathological conditions. Hence an important part of this study concerns the optimization and validation of an ultrafiltration technique for quantifying the non-protein-bound copper fraction in undiluted serum samples. The basic technique, successfully applied to the measurement of numerous non-proteinbound analytes in serum (e.g., 9, 12), is apparently just as useful for quantifying the ultrafiltrable copper fraction in human serum. An advantage of the MI'S-i device is that it can produce various volumes of ultrafiltrate in a single operation without having to reload the system, by simply prolonging the centrifugation time. Thus, several analytes in addition to non-protein-bound copper can be measured in a single processing of a serum specimen.
Acceptable assay precision
was obtained by strict control of centrifugation force, time, and temperature. Under these conditions, the excellent sensitivity of the measuring system, a detection limit of about 0.025 zmol/L, was much below the expected mean value for the non-protein-bound copper fraction found in normal human sera. We carried out additional experiments to validate (albeit indirectly because of no access to radioisotope use) the reliability of our proposed method. The cumulative findings of these experiments-which included estimations of recovery of standard copper solutions, albumin binding, step-wise saturation of copper-binding sites in serum, and adding the chelator EDTA-indicate the appropriateness and suitability of the optimized technique for measuring the NPBCu fraction in human serum.
The mean NPBCu concentration in serum in normal nonpregnant women was 0.253 (±0.062) tmoJJL, or about 1.4% of the total copper content in serum. In pregnant women the mean value was 0.262 (±0.069), -0.9% of the total copper concentration. In cord blood samples, the mean value was 0.247 (± 0.074), about 3.6% of the total copper content. This interesting variation in the percentage of total copper that is NPBCu suggests a fine regulatory mechanism for NPBCu concentration in blood, a mechanism different, but not necessarily independent, from those governing ceruloplasmin-bound and other copper-containing fractions.
The concentration of NPBCu that we found in serum of normal subjects is about the same as that estimated by investigators utilizing other techniques such as chromatography: <5% of total serum copper (2,3). In contrast, results from our albumin binding, serum saturation, and EDTA chelation experiments indicate a very large spare capacity for mediated copper transport in serum.
The importance of copper in human pregnancy is widely recognized and the well-established increase of plasma copper during normal or complicated pregnancy is invariably attributed to an increase in the concentration of ceruloplasmin (13) (14) (15) (16) . Thus, as expected, total ceruloplasmm-bound concentrations of copper in serum differed significantly between the three groups of subjects examined (i.e., normal, pregnant, and cord blood). However, the NPBCu concentration was not significantly different between the same three groups. These findings support the idea that in adults it is mainly changes in ceruloplasmin that induce variation in the concentrations of total copper under physiological conditions. Nevertheless, it remains to be seen whether the size of the loosely protein-bound fraction varies in these circumstances.
The mean ratio for maternal to cord blood total copper was 4.8; that for ceruloplasmin was 3.5. The difference between these two ratios either suggests a significant decrease from maternal to cord values for the non-ceruloplasmin-bound copper fraction, or indicates that the number of copper atoms per ceruloplasmin molecule is less in fetal circulation. However, the former suggestion is contrary to a report (2) that the non-ceruloplasmin-bound copper fraction was greater in cord blood than in maternal blood.
Investigations directed toward the elucidation of possible associations among the three variables studied (i.e., total copper, ceruloplasmin, and NPBCu) in separate analyses of normal, pregnant, and cord blood, together with the additional analysis involving the same variables but performed on paired maternal-cord samples, revealed important and new information.
Thus, ceruloplasmin concentrations correlated significantly and positively with concentrations of total copper in both normal controls (r = 0.567, P <0.01) and pregnant women (r =0.389, P <0. 
